Risk stratification in prostate cancer remains a significant clinical challenge. A study in this issue of the JCI describes an exciting application of high-throughput functional genomic technology to further refine our understanding of treatment failure risk in prostate cancer patients .
James McKiernan, Mitchell C. Benson
Title and authors | Publication | Year |
---|---|---|
Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers
Xu B, Gao L, Wang L, Tang G, He M, Yu Y, Ni X, Sun Y |
British Journal of Cancer | 2013 |